Example: dental hygienist
NEW ZEALAND DATA SHEET - Medsafe
COPAXONE 20 & 40 mg/mL PI_6 June 2018 V3.0 Page 2 of 21 4.2 Dose and method of administration Copaxone 20 mg/mL The recommended dosage in adults is a once daily subcutaneous injection of 1 mL Copaxone 20 mg.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
An information guide for patients diagnosed with Partial ...
www.cuh.hse.ie2 What is a molar pregnancy? A molar pregnancy is also called a ‘hydatidiform mole’ pregnancy. It happens when a man’s sperm joins the woman’s egg, but normal conception of a
Molar Pregnancy: A Case Study - Houston Children’s Hospital
www.childrens.memorialhermann.orgScoring System for GTN Risk Factor 0 1 2 4 Age (years) <=39 >39 ‐‐ Antecedent pregnancy Mole Abortion Term ‐ Pregnancy event to treatmentinterval
A Systematic Approach for the Assessment and Diagnosis of ...
www.aapsus.org160 American Journal of Clinical Medicine® • Fall 2011 • Volume Eight, Number Three A Systematic Approach for the Assessment and Diagnosis . . . Abstract The complaint of abdominal pain in a premenopausal female is a challenging task for any medical provider faced with making
POSTAL REGISTRATION FORM FOR PATIENTS HAVING …
www.hmole-chorio.org.ukPOSTAL REGISTRATION FORM FOR PATIENTS HAVING HYDATIDIFORM MOLE Registration is now ONLINE:Go to https://nww.h-mole.nhs.uk Alternatively this form may be used. Please read the supplementary notes before completing this form.
SUMMARY OF PRODUCT CHARACTERISTICS - Sanofi
www.sanofi-aventis.co.ukSUMMARY OF PRODUCT CHARACTERISTICS 1 Name of the medicinal product Depakote 250mg Tablets. Depakote 500mg Tablets. 2 Qualitative and quantitative composition
GESTATIONAL TROPHOBLASTIC NEOPLASIA - WHO | World …
www.who.intGESTATIONAL TROPHOBLASTIC NEOPLASIA Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines